Lexeo Therapeutics price target rises to $26.12 across 8 analysts
According to estimates from 8 analysts, the average price target for Lexeo Therapeutics shares rose from $25.11 to $26.12, with forecasts ranging from $9 to $42 per share. Using the November 20, 2026 closing price as a reference, the new target implies a potential upside of about 783%. The consensus rating from the 8 analysts remains "buy": 8 buy, 0 hold and 0 sell.
In 30 seconds
- The average price target from 8 analysts rises from $25.11 to $26.12 per share
- Forecasts range from $9 to $42 per share
- The new target implies a potential upside of 783% versus the November 20, 2026 close
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.